Zexian Liu

25.2k citations
181 papers · 7.8k indexed · 4 hit papers · h-index 44
Topics
RNA modifications and cancer (28 papers)Advanced Optimization Algorithms Research (23 papers)Cancer-related molecular mechanisms research (22 papers)

In The Last Decade

Zexian Liu

170 papers receiving 7.7k citations

Hit Papers

HemI: A Toolkit for Illustrating Heatmaps20142026201820222014201920192022250500750

Peers

Zexian Liu
Comparison fields: 5 of 167
  • Molecular Biology 5.2k
  • Cancer Research 2.1k
  • Oncology 1.2k
  • Pulmonary and Respiratory Medicine 856
  • Immunology 640
Replace Jinhua Wang with:
Jinhua Wang China
Ursula Klingmüller Germany
Meiling Zhang China
Seung Joon Baek United States
Ping Gao China
Ming Li China
Dong Li China
Hsueh‐Wei Chang Taiwan
Clemens Kreutz Germany
Xiaofei Wang China
Zexian Liu relative to Jinhua Wang China Jinhua Wang's profile →
Citations per field
00.5×1.5×
Jinhua Wang · 1×
Citations per year

Countries citing papers authored by Zexian Liu

Since Specialization
Citations

This map shows the geographic impact of Zexian Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zexian Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zexian Liu more than expected).

Fields of papers citing papers by Zexian Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zexian Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zexian Liu. The network helps show where Zexian Liu may publish in the future.

Co-authorship network of co-authors of Zexian Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Zexian Liu. A scholar is included among the top collaborators of Zexian Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zexian Liu. Zexian Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 12
3 44
4 1
5 13
6 2
7 4
8 30
9 19
10 40
11 3
12 59
13 4
14 3
15 19
16 163
17 21
18 24
19 95
20 34

About Zexian Liu

Zexian Liu is a scholar working on Numerical Analysis, Cancer Research and Molecular Biology, having authored 181 papers that have together received 7.8k indexed citations. Recurring topics across this work include RNA modifications and cancer (28 papers), Advanced Optimization Algorithms Research (23 papers) and Cancer-related molecular mechanisms research (22 papers). The work is most often cited by research in Cancer Research (2.1k citations), Molecular Biology (5.2k citations) and Oncology (1.2k citations). Zexian Liu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yu Xue, Han Cheng, Yongbo Wang, Jian Ren, Wankun Deng, Qi Zhao, Rui‐Hua Xu, Huai‐Qiang Ju, Xinjiao Gao and Hongwei Liu. Their work appears in journals such as Nucleic Acids Research, Advanced Materials and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026